Residual coronary artery disease (CAD), as assessed by the SYNTAX score, following treatment of degenerative and functional mitral regurgitation (MR) with transcatheter mitral valve repair (TMVr) using the MitraClip, was associated with worse mortality at 1 year, according to a study released Monday.